| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2872197 | The Annals of Thoracic Surgery | 2015 | 8 Pages |
Abstract
Midterm follow-up shows acceptable hemodynamic performance of the Mitroflow biologic aortic valve prosthesis in selected patients 60 years old and older. Ongoing follow-up will be necessary to understand long-term performance and outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mahesh MD, Rakesh M. MD, DPhil, Murat MD, Kevin L. MD, John M. MD, Joseph A. MD, Lyle D. MD, Alberto MD, Zhuo MS, Hartzell V. MD,